IRBESARTAN: HYDROCHLOROTHIAZIDE

Search structure
Trade Names:
Status: Approved
Entry Type: Unknown
Molecule Category: UNKNOWN

Adverse Reactions

SOC By Demographic Distribution
System Organ Classification (SOC)
Relative Frequency (%)
Skin and subcutaneous tissue disorders
15.19
Nervous system disorders
13.92
General disorders and administration site conditions
12.66
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
11.39
Psychiatric disorders
7.59
Eye disorders
5.06
Immune system disorders
5.06
Metabolism and nutrition disorders
5.06
Cardiac disorders
3.8
Investigations
3.8
Musculoskeletal and connective tissue disorders
3.8
Product issues
3.8
Endocrine disorders
2.53
Injury, poisoning and procedural complications
2.53
CONTENTS